NCT02068170View on ClinicalTrials.gov

Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital

CompletedOBSERVATIONAL
Enrollment

178

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

June 30, 2015

Conditions
DeliriumQT-prolongation
Interventions
DRUG

Haloperidol, azi/clari/erythromycin, levo/moxifloxacin, co-trimoxazole, vori/keto/flu/itraconazole, methadone, tacrolimus, sunitinib

Trial Locations (1)

3000

UZ Leuven, Leuven

All Listed Sponsors
collaborator

Agentschap voor Innovatie door Wetenschap en Technologie

OTHER

lead

KU Leuven

OTHER

NCT02068170 - Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital | Biotech Hunter | Biotech Hunter